• Join
  • Login
  • Contact

Search abstracts

Optimising human factors within regulatory processes to accelerate safe biopharmaceutical innovation

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: PARSONS, Andrew (Reciprocal Minds Limited)
  • Co-author(s): Andrew Parsons: Reciprocal Minds Limited, Welwyn Garden City, United Kingdom
    Allison Morgan: Metis Clinical, Ascot, United Kingdom
    Simon Whiteley: Whiteley Aerospace Safety Engineering & Management Limited, Swindon, United Kingdom
    Crystal Ruff: Illumina, Cambridge, United Kingdom
    Fiona Day: Beaconbrands , London, United Kingdom
    Julia Mironova: Beaconbrands, London, United Kingdom
    Brian Edwards: NDA Regulatory Science Ltd, Leatherhead, United Kingdom
  • Abstract:


    Human factors (HF) allow optimisation of the interface between people and all aspects of a system. Despite recent technological advances, the basic principles of medicines development have not changed since the ’80 and have been stated to be “broken” [1].


    Using a system engineering model (STAMP) [2] the BP development process was


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses